"NEW ORLEANS — At least 1 year of testosterone therapy did not reduce anti-Müllerian hormone levels or antral follicular count in a cohort of transgender men in Israel, providing evidence for preserved ovarian reserve, according to data presented at The Endocrine Society Annual Meeting…"
"Yaish I, et al. OR11-3. Evidence for preserved ovarian reserve in transgender men receiving testosterone therapy: Anti-Mullerian hormone serum levels decrease modestly after one year of treatment. Presented at: The Endocrine Society Annual Meeting; March 23-26, 2019; New Orleans."